Ascentage Pharma
AstraZeneca
Bristol Myers Squibb
Fusion Pharmaceuticals
Incyte Pharmaceutical
Merck
Novartis
Pfizer
Takeda Pharmaceuticals
Teva Pharmaceutical
Published | Pages | Publisher | Report code |
---|---|---|---|
Apr 2022 | 240 | Kuick Research | ASDR-599041 |
Ascentage Pharma
AstraZeneca
Bristol Myers Squibb
Fusion Pharmaceuticals
Incyte Pharmaceutical
Merck
Novartis
Pfizer
Takeda Pharmaceuticals
Teva Pharmaceutical